Homologous recombination of wild-type JAK2, a novel early step in the development of myeloproliferative neoplasm.
作者： Mathias Vilaine , Damla Olcaydu , Ashot Harutyunyan , Jonathan Bergeman , Mourad Tiab
DOI: 10.1182/BLOOD-2011-08-372813
关键词:
摘要: To the editor: Transformation of hematopoietic cells depends on acquisition genetic events leading to cytokine independence, typically associated with an autocrine loop or/and increased expression mutation JAK genes.[1][1] Rearrangement JAK2 gene,
ashpublications.org
bloodjournal.org参考文章(10)
T. Hornakova, L. Springuel, J. Devreux, A. Dusa, S. N. Constantinescu, L. Knoops, J.-C. Renauld, Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors Haematologica. ,vol. 96, pp. 845- 853 ,(2011) , 10.3324/HAEMATOL.2010.036350
M Boissinot, C Cleyrat, M Vilaine, Y Jacques, I Corre, S Hermouet, Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F Oncogene. ,vol. 30, pp. 990- 1001 ,(2011) , 10.1038/ONC.2010.479
Robert Kralovics, Yongli Guan, Josef T Prchal, None, Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera Experimental Hematology. ,vol. 30, pp. 229- 236 ,(2002) , 10.1016/S0301-472X(01)00789-5
James R Lupski, Pawel Stankiewicz, Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLOS Genetics. ,vol. 1, ,(2005) , 10.1371/JOURNAL.PGEN.0010049
Ralph Tiedt, Hui Hao-Shen, Marta A. Sobas, Renate Looser, Stephan Dirnhofer, Jürg Schwaller, Radek C. Skoda, Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice Blood. ,vol. 111, pp. 3931- 3940 ,(2007) , 10.1182/BLOOD-2007-08-107748
Damla Olcaydu, Ashot Harutyunyan, Roland Jäger, Tiina Berg, Bettina Gisslinger, Ingrid Pabinger, Heinz Gisslinger, Robert Kralovics, A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms Nature Genetics. ,vol. 41, pp. 450- 454 ,(2009) , 10.1038/NG.341
Chloé James, Valérie Ugo, Jean-Pierre Le Couédic, Judith Staerk, François Delhommeau, Catherine Lacout, Loïc Garçon, Hana Raslova, Roland Berger, Annelise Bennaceur-Griscelli, Jean Luc Villeval, Stefan N. Constantinescu, Nicole Casadevall, William Vainchenker, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature. ,vol. 434, pp. 1144- 1148 ,(2005) , 10.1038/NATURE03546
Katrien Van Roosbroeck, Luk Cox, Thomas Tousseyn, Idoya Lahortiga, Olga Gielen, Barbara Cauwelier, Pascale De Paepe, Gregor Verhoef, Peter Marynen, Peter Vandenberghe, Chris De Wolf-Peeters, Jan Cools, Iwona Wlodarska, JAK2 Rearrangements, Including the Novel SEC31A-JAK2 Fusion, Are Recurrent in Classical Hodgkin Lymphoma Blood. ,vol. 117, pp. 4056- 4064 ,(2009) , 10.1182/BLOOD-2010-06-291310
Eric Lippert, Marjorie Boissinot, Robert Kralovics, François Girodon, Irène Dobo, Vincent Praloran, Nathalie Boiret-Dupré, Radek C. Skoda, Sylvie Hermouet, The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera Blood. ,vol. 108, pp. 1865- 1867 ,(2006) , 10.1182/BLOOD-2006-01-013540
Thorsten Klampfl, Ashot Harutyunyan, Tiina Berg, Bettina Gisslinger, Martin Schalling, Klaudia Bagienski, Damla Olcaydu, Francesco Passamonti, Elisa Rumi, Daniela Pietra, Roland Jäger, Lisa Pieri, Paola Guglielmelli, Ilaria Iacobucci, Giovanni Martinelli, Mario Cazzola, Alessandro M. Vannucchi, Heinz Gisslinger, Robert Kralovics, Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression Blood. ,vol. 118, pp. 167- 176 ,(2011) , 10.1182/BLOOD-2011-01-331678